Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    STRATA Skin Sciences Inc.

    NASDAQ: SSKN · Real-Time Price · USD
    2.20
    -0.05 (-2.22%)
    At close: Jun 13, 2025, 3:59 PM
    2.16
    -1.82%
    After-hours: Jun 13, 2025, 05:07 PM EDT

    STRATA Skin Sciences Statistics

    Share Statistics

    STRATA Skin Sciences has 4.17M shares outstanding. The number of shares has increased by 18.97% in one year.

    Shares Outstanding

    n/a
    		 4.17M

    Shares Change (YoY)

    n/a
    		 18.97%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.03%

    Shares Floating

    n/a
    		 2.57M

    Failed to Deliver (FTD) Shares

    n/a
    		 223

    FTD / Avg. Volume

    n/a
    		 2.92%

    Short Selling Information

    The latest short interest is 5.07K, so 0.12% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.07K

    Short % of Shares Out

    n/a
    		 0.12%

    Short % of Float

    n/a
    		 0.23%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.1 and the forward PE ratio is -4.12. STRATA Skin Sciences's PEG ratio is 0.08.

    PE Ratio

    n/a
    		 -1.1

    Forward PE

    n/a
    		 -4.12

    PS Ratio

    n/a
    		 0.33

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 2.23

    P/FCF Ratio

    n/a
    		 -7.65

    PEG Ratio

    n/a
    		 0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for STRATA Skin Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.13, with a Debt / Equity ratio of 3.31.

    Current Ratio

    n/a
    		 1.13

    Quick Ratio

    n/a
    		 0.98

    Debt / Equity

    n/a
    		 3.31

    Debt / EBITDA

    n/a
    		 -5.78

    Debt / FCF

    n/a
    		 -11.35

    Interest Coverage

    n/a
    		 -4.39

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $316,622.64

    Profits Per Employee

    n/a
    		 $-95,150.94

    Employee Count

    n/a
    		 106

    Asset Turnover

    n/a
    		 0.93

    Inventory Turnover

    n/a
    		 6.45

    Taxes

    Income Tax

    n/a
    		 -170K

    Effective Tax Rate

    n/a
    		 1.66%

    Stock Price Statistics

    The stock price has increased by -28.29% in the last 52 weeks. The beta is 0.71, so STRATA Skin Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.71

    52-Week Price Change

    n/a
    		 -28.29%

    50-Day Moving Average

    n/a
    		 2.55

    200-Day Moving Average

    n/a
    		 2.84

    Relative Strength Index (RSI)

    n/a
    		 39

    Average Volume (20 Days)

    n/a
    		 7,642

    Income Statement

    In the last 12 months, STRATA Skin Sciences had revenue of 33.56M and earned -10.09M in profits. Earnings per share was -2.65.

    Revenue

    n/a
    		 33.56M

    Gross Profit

    n/a
    		 19.08M

    Operating Income

    n/a
    		 -9.26M

    Net Income

    n/a
    		 -10.09M

    EBITDA

    n/a
    		 -2.84M

    EBIT

    n/a
    		 -8.15M

    Earnings Per Share (EPS)

    n/a
    		 -2.65
    Full Income Statement

    Balance Sheet

    The company has 7.26M in cash and 16.44M in debt, giving a net cash position of -9.18M.

    Cash & Cash Equivalents

    n/a
    		 7.26M

    Total Debt

    n/a
    		 16.44M

    Net Cash

    n/a
    		 -9.18M

    Retained Earnings

    n/a
    		 -248.14M

    Total Assets

    n/a
    		 34.26M

    Working Capital

    n/a
    		 737K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 188K and capital expenditures -1.64M, giving a free cash flow of -1.45M.

    Operating Cash Flow

    n/a
    		 188K

    Capital Expenditures

    n/a
    		 -1.64M

    Free Cash Flow

    n/a
    		 -1.45M

    FCF Per Share

    n/a
    		 -0.38
    Full Cash Flow Statement

    Margins

    Gross margin is 56.85%, with operating and profit margins of -27.58% and -30.05%.

    Gross Margin

    n/a
    		 56.85%

    Operating Margin

    n/a
    		 -27.58%

    Pretax Margin

    n/a
    		 -30.56%

    Profit Margin

    n/a
    		 -30.05%

    EBITDA Margin

    n/a
    		 -8.47%

    EBIT Margin

    n/a
    		 -27.58%

    FCF Margin

    n/a
    		 -4.31%

    Dividends & Yields

    SSKN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SSKN is $6, which is 175.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 175.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 7, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jun 7, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -9.74

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist